CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Polymeropoulos Mihael Hristos President and CEO | Shares withheld for taxes | −95,999 | $4.76 | $457K | 2,265,731 |
| 2025-03-01 | Moran Kevin Patrick SVP, CFO & Treasurer | Shares withheld for taxes | −26,941 | $4.76 | $128K | 328,822 |
| 2025-03-01 | Williams Timothy SVP & General Counsel | Shares withheld for taxes | −26,941 | $4.76 | $128K | 294,884 |
| 2025-02-28 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +10,000 | $4.76 | $48K | 2,361,730 |
| 2025-02-27 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +10,000 | $4.76 | $48K | 2,351,730 |
| 2025-02-26 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $4.75 | $24K | 2,336,730 |
| 2025-02-26 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $4.78 | $24K | 2,341,730 |
| 2025-02-25 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +10,000 | $4.46 | $45K | 2,331,730 |
| 2025-02-21 | Moran Kevin Patrick SVP, CFO & Treasurer | Purchase | +2,000 | $4.39 | $9K | 355,763 |
| 2025-02-18 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award | +125,000 | 254,789 | ||
| 2025-02-18 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +450,000 | 2,321,730 | ||
| 2025-02-18 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award | +125,000 | 353,763 | ||
| 2025-02-18 | Birznieks Gunther SVP, Business Development | Grant or award | +125,000 | 438,569 | ||
| 2025-02-18 | Williams Timothy SVP & General Counsel | Grant or award | +125,000 | 321,825 | ||
| 2024-11-14 | Mitchell Stephen Ray Director | Sale | −5,000 | $5.17 | $26K | 44,857 |
| 2024-07-29 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −2,251 | $5.92 | $13K | 228,763 |
| 2024-05-22 | Chrousos Phaedra Director | Grant or award | +21,887 | 64,125 | ||
| 2024-05-22 | Chrousos Phaedra Director | Grant or award · Stock Option (right to buy) | +40,202 | 40,202 | ||
| 2024-05-17 | Honore Tage Director | Grant or award | +20,529 | 64,244 | ||
| 2024-05-17 | Honore Tage Director | Grant or award · Stock Option (right to buy) | +37,578 | 37,578 |
Page 3 of 8 · 153 trades